Allos leverages hospital Electronic Health Record data to design and improve pharma clinical trials using a revolutionary causal AI. Image Problem Pharma clinical trials are getting increasingly expensive. There are more comorbidities and an ever-increasing number of endpoints, making clinical trials significantly more complex and costly. Solution Allos leverages hospital Electronic Health Record data to design pharma clinical trials using a revolutionary causal AI. Causality is the only technology that can account for comorbidities and increasing endpoints. This allows us to design unbiased and robust clinical trials from the ground up. Market Our initial focus is on inflammatory arthritis. Globally, the market for clinical trials for this condition is worth £18 billion and the wider autoimmune clinical trials market stands at £73 billion. Contact Allos website Allos LinkedIn This article was published on 2024-09-30
